1. Home
  2. GRI vs FLYE Comparison

GRI vs FLYE Comparison

Compare GRI & FLYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GRI Bio Inc.

GRI

GRI Bio Inc.

HOLD

Current Price

$1.71

Market Cap

3.0M

Sector

Health Care

ML Signal

HOLD

Logo Fly-E Group Inc.

FLYE

Fly-E Group Inc.

HOLD

Current Price

$1.67

Market Cap

2.7M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRI
FLYE
Founded
2018
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.0M
2.7M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
GRI
FLYE
Price
$1.71
$1.67
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$160.00
N/A
AVG Volume (30 Days)
364.3K
8.6K
Earning Date
05-15-2026
04-21-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
61.82
EPS
N/A
N/A
Revenue
N/A
$19,063,357.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.18
$0.48
52 Week High
$6.70
$21.80

Technical Indicators

Market Signals
Indicator
GRI
FLYE
Relative Strength Index (RSI) 51.97 42.44
Support Level $1.71 $1.64
Resistance Level $2.30 $2.30
Average True Range (ATR) 0.20 0.09
MACD 0.04 0.01
Stochastic Oscillator 31.34 35.00

Price Performance

Historical Comparison
GRI
FLYE

About GRI GRI Bio Inc.

GRI Bio Inc is a clinical-stage biotech company focused on discovering, developing, and commercializing therapies targeting serious diseases associated with dysregulated immune responses that to inflammatory, fibrotic, and autoimmune disorders. GRI Bio's program, GRI-0621, is a small molecule RAR-beta and gamma dual agonist that inhibits the activity of human NKT I cells, returning the immune system to homeostasis. It is also an oral formulation of tazarotene, a synthetic RAR-beta and gamma selective agonist for the topical treatment of psoriasis and acne. The company's other product candidate GRI-0803 is a novel oral agonist of type 2 Natural Killer T (type 2 NKT) cells which can be a potential treatment for autoimmune disorders.

About FLYE Fly-E Group Inc.

Fly-E Group Inc is principally engaged in designing, installing, and selling smart electric motorcycles, electric bikes, electric scooters, and related accessories under the Fly E-Bike brand. The Company encourages the adoption of eco-friendly transportation for active lifestyles.

Share on Social Networks: